CMR Naviscan Corporation software

A New Standard of Care in Early Breast Cancer Detection. Even when a mammogram is deemed negative, additional adjunctive tests, such as Molecular Breast Imaging (MBI), for women with dense breast tissue or who are considered high-risk for breast cancer should be considered. When a patient is determined to have dense breast tissue, or has a suspicious mammogram, MBI offers a secondary screening option for breast cancer imaging that is more sensitive and specific. As a functional imaging modality, MBI provides the ability to have confidence in the diagnosis, and provide patients and physicians alike with peace of mind.